Smad2 and smad3 are redundantly essential for the suppression of inos synthesis in macrophages by regulating IRF3 and STAT1 pathways

Yuki Sugiyama, Kyosuke Kakoi, Akihiro Kimura, Ichiro Takada, Ikko Kashiwagi, Yu Wakabayashi, Rimpei Morita, Masatoshi Nomura, Akihiko Yoshimura

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Although transforming growth factor (TGF)-β1 is a well-known immunosuppressive cytokine, little is known about the role of its downstream transcription factors, Smad2 and Smad3, in the suppression of macrophage activation. Previous studies have demonstrated that Smad3 is critical for the suppression of LPS-mediated inducible nitric oxide (NO) synthase (iNOS) induction, although the role of Smad2 remains to be investigated. In this study, we found that iNOS induction was enhanced in Smad2-deficient bone marrow-derived macrophages (BMDMs) and peritoneal macrophages in vitro and tumor-associated macrophages in vivo, compared with wild-type (WT) macrophages. However, TGF-β1 still suppressed iNOS induction in Smad2-deficient macrophages. In Smad2/3 double knockout (KO) (Smad2/3 DKO) BMDMs, LPS-mediated NO/iNOS induction was more strongly elevated than in Smad2 or Smad3 single KO BMDMs, and its suppression by exogenous TGF-β1 was severely impaired. These data suggest that Smad2 and Smad3 redundantly regulate iNOS induction. Similarly, the production of IL-6 and TNFα, but not IL-10 was augmented in Smad2/3 DKO BMDMs, suggesting that Smad2 and Smad3 also redundantly suppressed some cytokines production. In Smad2/3 DKO macrophages, TLR3- as well as TLR4-mediated IRF3 activation and IFN-β production were strongly augmented, which resulted in hyper STAT1 phosphorylation. Furthermore, IFN-β- and IFN-γ-induced iNOS induction in the absence of TLR signaling and STAT1 transcriptional activity were augmented in Smad2/3 DKO BMDMs. These results suggest that Smad2 and Smad3 negatively regulate iNOS induction in macrophages by suppressing multiple steps in the IRF3-IFN-β-STAT1 pathway.

Original languageEnglish
Pages (from-to)253-265
Number of pages13
JournalInternational Immunology
Volume24
Issue number4
DOIs
Publication statusPublished - 2012

Fingerprint

Macrophages
Transforming Growth Factors
Cytokines
Macrophage Activation
Peritoneal Macrophages
Nitric Oxide Synthase Type II
Immunosuppressive Agents
Interleukin-10
Interleukin-6
Nitric Oxide
Transcription Factors
Phosphorylation
Neoplasms

Keywords

  • Immunosuppression
  • Signal transduction
  • TGF-β
  • TLR

ASJC Scopus subject areas

  • Immunology

Cite this

Smad2 and smad3 are redundantly essential for the suppression of inos synthesis in macrophages by regulating IRF3 and STAT1 pathways. / Sugiyama, Yuki; Kakoi, Kyosuke; Kimura, Akihiro; Takada, Ichiro; Kashiwagi, Ikko; Wakabayashi, Yu; Morita, Rimpei; Nomura, Masatoshi; Yoshimura, Akihiko.

In: International Immunology, Vol. 24, No. 4, 2012, p. 253-265.

Research output: Contribution to journalArticle

Sugiyama, Yuki ; Kakoi, Kyosuke ; Kimura, Akihiro ; Takada, Ichiro ; Kashiwagi, Ikko ; Wakabayashi, Yu ; Morita, Rimpei ; Nomura, Masatoshi ; Yoshimura, Akihiko. / Smad2 and smad3 are redundantly essential for the suppression of inos synthesis in macrophages by regulating IRF3 and STAT1 pathways. In: International Immunology. 2012 ; Vol. 24, No. 4. pp. 253-265.
@article{c6ccb42ea6784514aa921fd3cbc77a87,
title = "Smad2 and smad3 are redundantly essential for the suppression of inos synthesis in macrophages by regulating IRF3 and STAT1 pathways",
abstract = "Although transforming growth factor (TGF)-β1 is a well-known immunosuppressive cytokine, little is known about the role of its downstream transcription factors, Smad2 and Smad3, in the suppression of macrophage activation. Previous studies have demonstrated that Smad3 is critical for the suppression of LPS-mediated inducible nitric oxide (NO) synthase (iNOS) induction, although the role of Smad2 remains to be investigated. In this study, we found that iNOS induction was enhanced in Smad2-deficient bone marrow-derived macrophages (BMDMs) and peritoneal macrophages in vitro and tumor-associated macrophages in vivo, compared with wild-type (WT) macrophages. However, TGF-β1 still suppressed iNOS induction in Smad2-deficient macrophages. In Smad2/3 double knockout (KO) (Smad2/3 DKO) BMDMs, LPS-mediated NO/iNOS induction was more strongly elevated than in Smad2 or Smad3 single KO BMDMs, and its suppression by exogenous TGF-β1 was severely impaired. These data suggest that Smad2 and Smad3 redundantly regulate iNOS induction. Similarly, the production of IL-6 and TNFα, but not IL-10 was augmented in Smad2/3 DKO BMDMs, suggesting that Smad2 and Smad3 also redundantly suppressed some cytokines production. In Smad2/3 DKO macrophages, TLR3- as well as TLR4-mediated IRF3 activation and IFN-β production were strongly augmented, which resulted in hyper STAT1 phosphorylation. Furthermore, IFN-β- and IFN-γ-induced iNOS induction in the absence of TLR signaling and STAT1 transcriptional activity were augmented in Smad2/3 DKO BMDMs. These results suggest that Smad2 and Smad3 negatively regulate iNOS induction in macrophages by suppressing multiple steps in the IRF3-IFN-β-STAT1 pathway.",
keywords = "Immunosuppression, Signal transduction, TGF-β, TLR",
author = "Yuki Sugiyama and Kyosuke Kakoi and Akihiro Kimura and Ichiro Takada and Ikko Kashiwagi and Yu Wakabayashi and Rimpei Morita and Masatoshi Nomura and Akihiko Yoshimura",
year = "2012",
doi = "10.1093/intimm/dxr126",
language = "English",
volume = "24",
pages = "253--265",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Smad2 and smad3 are redundantly essential for the suppression of inos synthesis in macrophages by regulating IRF3 and STAT1 pathways

AU - Sugiyama, Yuki

AU - Kakoi, Kyosuke

AU - Kimura, Akihiro

AU - Takada, Ichiro

AU - Kashiwagi, Ikko

AU - Wakabayashi, Yu

AU - Morita, Rimpei

AU - Nomura, Masatoshi

AU - Yoshimura, Akihiko

PY - 2012

Y1 - 2012

N2 - Although transforming growth factor (TGF)-β1 is a well-known immunosuppressive cytokine, little is known about the role of its downstream transcription factors, Smad2 and Smad3, in the suppression of macrophage activation. Previous studies have demonstrated that Smad3 is critical for the suppression of LPS-mediated inducible nitric oxide (NO) synthase (iNOS) induction, although the role of Smad2 remains to be investigated. In this study, we found that iNOS induction was enhanced in Smad2-deficient bone marrow-derived macrophages (BMDMs) and peritoneal macrophages in vitro and tumor-associated macrophages in vivo, compared with wild-type (WT) macrophages. However, TGF-β1 still suppressed iNOS induction in Smad2-deficient macrophages. In Smad2/3 double knockout (KO) (Smad2/3 DKO) BMDMs, LPS-mediated NO/iNOS induction was more strongly elevated than in Smad2 or Smad3 single KO BMDMs, and its suppression by exogenous TGF-β1 was severely impaired. These data suggest that Smad2 and Smad3 redundantly regulate iNOS induction. Similarly, the production of IL-6 and TNFα, but not IL-10 was augmented in Smad2/3 DKO BMDMs, suggesting that Smad2 and Smad3 also redundantly suppressed some cytokines production. In Smad2/3 DKO macrophages, TLR3- as well as TLR4-mediated IRF3 activation and IFN-β production were strongly augmented, which resulted in hyper STAT1 phosphorylation. Furthermore, IFN-β- and IFN-γ-induced iNOS induction in the absence of TLR signaling and STAT1 transcriptional activity were augmented in Smad2/3 DKO BMDMs. These results suggest that Smad2 and Smad3 negatively regulate iNOS induction in macrophages by suppressing multiple steps in the IRF3-IFN-β-STAT1 pathway.

AB - Although transforming growth factor (TGF)-β1 is a well-known immunosuppressive cytokine, little is known about the role of its downstream transcription factors, Smad2 and Smad3, in the suppression of macrophage activation. Previous studies have demonstrated that Smad3 is critical for the suppression of LPS-mediated inducible nitric oxide (NO) synthase (iNOS) induction, although the role of Smad2 remains to be investigated. In this study, we found that iNOS induction was enhanced in Smad2-deficient bone marrow-derived macrophages (BMDMs) and peritoneal macrophages in vitro and tumor-associated macrophages in vivo, compared with wild-type (WT) macrophages. However, TGF-β1 still suppressed iNOS induction in Smad2-deficient macrophages. In Smad2/3 double knockout (KO) (Smad2/3 DKO) BMDMs, LPS-mediated NO/iNOS induction was more strongly elevated than in Smad2 or Smad3 single KO BMDMs, and its suppression by exogenous TGF-β1 was severely impaired. These data suggest that Smad2 and Smad3 redundantly regulate iNOS induction. Similarly, the production of IL-6 and TNFα, but not IL-10 was augmented in Smad2/3 DKO BMDMs, suggesting that Smad2 and Smad3 also redundantly suppressed some cytokines production. In Smad2/3 DKO macrophages, TLR3- as well as TLR4-mediated IRF3 activation and IFN-β production were strongly augmented, which resulted in hyper STAT1 phosphorylation. Furthermore, IFN-β- and IFN-γ-induced iNOS induction in the absence of TLR signaling and STAT1 transcriptional activity were augmented in Smad2/3 DKO BMDMs. These results suggest that Smad2 and Smad3 negatively regulate iNOS induction in macrophages by suppressing multiple steps in the IRF3-IFN-β-STAT1 pathway.

KW - Immunosuppression

KW - Signal transduction

KW - TGF-β

KW - TLR

UR - http://www.scopus.com/inward/record.url?scp=84859207428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859207428&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxr126

DO - 10.1093/intimm/dxr126

M3 - Article

VL - 24

SP - 253

EP - 265

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 4

ER -